London, UK, March 29, 2019 (GLOBE NEWSWIRE) -- Defibrillators are essential in improving the quality of life and overall well-being. The defibrillators industry is highly competitive and diverse with immense potential growth. Drivers for growth include availability of technologically advanced defibrillators, rapidly growing aging population leading to high risk of cardiovascular diseases, growing incidence of cardiovascular diseases and increasing awareness and training programmes related to defibrillators.
For free sample pages on this report please click on:
https://www.visiongain.com/report/global-defibrillators-market-forecast-2019-2029/
The lead analyst of the report commented “Growth in this market is set to be driven by the availability of technologically advanced defibrillators, rapidly growing aging population leading to high risk of cardiovascular diseases, growing incidence of cardiovascular diseases and increasing awareness and training programmes related to defibrillators. However, lack of awareness about sudden cardiac arrest, issues related to the use of defibrillator devices (external and implantable), and unfavourable healthcare reforms in the U.S. are some of the key factors restraining the growth of this market. In addition to this, increasing pricing pressure on market players and frequent product recalls pose major challenges to defibrillator manufacturers.”
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 207 549 9987.
Leading companies featured in the report include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, LivaNova PLC, Medtronic PLC, Nihon Kohden Corporation, Phillips Healthcare, Physio Control Inc., Zoll Medical Corporation
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 207 549 9987.
For more pharma reports please visit https://www.visiongain.com/industries/pharma/
About visiongain
Visiongain is one of the fastest-growing and most innovative independent business intelligence providers in Europe.
Based in London, UK, Visiongain publishes independent and insightful market reports across a wide range of industry verticals, including automotive, chemical, cyber, defence, energy, pharmaceutical, materials and many more sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. The company has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original business intelligence to depend upon.
https://www.visiongain.com/